Loading...

Development of Novel Radiosensitizers through the National Cancer Institute’s Small Business Innovation Research Program

While radiosensitizing chemotherapy has improved survival for several types of cancer, current chemoradiation regimens remain ineffective for many patients and have substantial toxicities. Given the strong need for the development of novel radiosensitizers to further improve patient outcomes, the Ra...

Full description

Saved in:
Bibliographic Details
Published in:Radiat Res
Main Authors: Zakeri, Kaveh, Narayanan, Deepa, Prasanna, Pataje G. S., Vikram, Bhadrasain, Buchsbaum, Jeffrey C.
Format: Artigo
Language:Inglês
Published: 2020
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7266046/
https://ncbi.nlm.nih.gov/pubmed/32216707
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1667/RR15545.1
Tags: Add Tag
No Tags, Be the first to tag this record!